IL13 and asthma: Bai et al. showed that vanillic acid at concentrations of 25 and 50 mg/kg mitigates airway inflammation in the OVA-induced rat asthma model via reducing inflammatory cells and TNF-α, IL-13, IL-5, and IL-4 levels and improving oxidative stress compared to dexamethasone (3 mg/kg) [142].